Unicycive Therapeutics Stock Forward View - Accumulation Distribution
| UNCY Stock | USD 6.69 0.50 8.08% |
Unicycive Stock outlook is based on your current time horizon.
At this time the rsi of Unicycive Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.56) | EPS Estimate Current Year (1.07) | EPS Estimate Next Year 5.9113 | Wall Street Target Price 46.5 | EPS Estimate Current Quarter (0.53) |
Using Unicycive Therapeutics hype-based prediction, you can estimate the value of Unicycive Therapeutics from the perspective of Unicycive Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Unicycive Therapeutics using Unicycive Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Unicycive using crowd psychology based on the activity and movement of Unicycive Therapeutics' stock price.
Unicycive Therapeutics Short Interest
An investor who is long Unicycive Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Unicycive Therapeutics and may potentially protect profits, hedge Unicycive Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 5.4019 | Short Percent 0.0767 | Short Ratio 3.73 | Shares Short Prior Month 1.6 M | 50 Day MA 6.2108 |
Unicycive Relative Strength Index
Unicycive Therapeutics Hype to Price Pattern
Investor biases related to Unicycive Therapeutics' public news can be used to forecast risks associated with an investment in Unicycive. The trend in average sentiment can be used to explain how an investor holding Unicycive can time the market purely based on public headlines and social activities around Unicycive Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Unicycive Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Unicycive Therapeutics.
Unicycive Therapeutics Implied Volatility | 1.95 |
Unicycive Therapeutics' implied volatility exposes the market's sentiment of Unicycive Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Unicycive Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Unicycive Therapeutics stock will not fluctuate a lot when Unicycive Therapeutics' options are near their expiration.
Unicycive Therapeutics after-hype prediction price | USD 6.64 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Unicycive | Build AI portfolio with Unicycive Stock |
Open Interest Against 2026-05-15 Unicycive Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Unicycive Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Unicycive Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Unicycive Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Unicycive Therapeutics' open interest, investors have to compare it to Unicycive Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Unicycive Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Unicycive. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Unicycive Therapeutics Additional Predictive Modules
Most predictive techniques to examine Unicycive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Unicycive using various technical indicators. When you analyze Unicycive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 0.087 | 0.087 |
| Check Unicycive Therapeutics Volatility | Backtest Unicycive Therapeutics | Information Ratio |
Unicycive Therapeutics Trading Date Momentum
| On February 09 2026 Unicycive Therapeutics was traded for 6.69 at the closing time. The top price for the day was 6.78 and the lowest listed price was 6.19 . There was no trading activity during the period 0.0. Lack of trading volume on February 9, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 7.47% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Unicycive Therapeutics to competition |
Other Forecasting Options for Unicycive Therapeutics
For every potential investor in Unicycive, whether a beginner or expert, Unicycive Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Unicycive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Unicycive. Basic forecasting techniques help filter out the noise by identifying Unicycive Therapeutics' price trends.Unicycive Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Unicycive Therapeutics stock to make a market-neutral strategy. Peer analysis of Unicycive Therapeutics could also be used in its relative valuation, which is a method of valuing Unicycive Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Unicycive Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Unicycive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Unicycive Therapeutics shares will generate the highest return on investment. By undertsting and applying Unicycive Therapeutics stock market strength indicators, traders can identify Unicycive Therapeutics entry and exit signals to maximize returns.
Unicycive Therapeutics Risk Indicators
The analysis of Unicycive Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Unicycive Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting unicycive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.88 | |||
| Semi Deviation | 4.29 | |||
| Standard Deviation | 4.69 | |||
| Variance | 22.02 | |||
| Downside Variance | 23.02 | |||
| Semi Variance | 18.44 | |||
| Expected Short fall | (4.17) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Unicycive Therapeutics
The number of cover stories for Unicycive Therapeutics depends on current market conditions and Unicycive Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Unicycive Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Unicycive Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Unicycive Therapeutics Short Properties
Unicycive Therapeutics' future price predictability will typically decrease when Unicycive Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Unicycive Therapeutics often depends not only on the future outlook of the potential Unicycive Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Unicycive Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Cash And Short Term Investments | 26.1 M |
Additional Tools for Unicycive Stock Analysis
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.